NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Common Equity (2010 - 2026)

NextPlat's (NXPL) quarterly Common Equity came in at $16.5 million in Q2 2026, down 28.35% year-over-year from $23.0 million in Q2 2025, and down 0.54% quarter-over-quarter from $16.6 million in Q1 2026.

Analysis

NextPlat (NXPL) Common Equity (2010 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Common Equity for 17 consecutive years, with $16.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Common Equity fell 28.35% year-over-year to $16.5 million in Q2 2026; TTM through Jun 2026 was $16.5 million, a 28.35% decrease from a year earlier, with the FY2025 full-year figure at $17.4 million, down 34.99% from the prior year.
  • Common Equity was $16.5 million for Q2 2026 at NextPlat, down from $16.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $49.5 million in Q3 2023 and troughed at $16.5 million in Q2 2026.
  • A 5-year average of $27.9 million and a median of $24.7 million in 2023 frame the typical range for Common Equity.
  • Across the five-year window, Common Equity surged 4012.86% in 2022 and plunged 47.23% in 2025, its largest moves.
  • Over 5 years, Common Equity stood at $25.8 million in 2022, then jumped by 86.56% to $48.1 million in 2023, then tumbled by 44.27% to $26.8 million in 2024, then sank by 34.99% to $17.4 million in 2025, then dropped by 5.38% to $16.5 million in 2026.
  • The last three Common Equity figures came in at $16.5 million (Q2 2026), $16.6 million (Q1 2026), and $17.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 7.76 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 14.26 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 4.08 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 33.02 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn -1.77 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 597.21 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -191.48 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 768.16 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 42.44 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 16.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.49 Mn
Mar 31, 2026 16.57 Mn
Dec 31, 2025 17.42 Mn
Sep 30, 2025 21.55 Mn
Jun 30, 2025 23.01 Mn
Mar 31, 2025 24.85 Mn
Dec 31, 2024 26.80 Mn
Sep 30, 2024 29.79 Mn
Jun 30, 2024 36.97 Mn
Mar 31, 2024 47.09 Mn
Dec 31, 2023 48.09 Mn
Sep 30, 2023 49.54 Mn
Jun 30, 2023 28.42 Mn
Mar 31, 2023 24.63 Mn
Dec 31, 2022 25.78 Mn
Sep 30, 2022 18.19 Mn
Jun 30, 2022 22.70 Mn
Mar 31, 2022 23.71 Mn
Dec 31, 2021 17.53 Mn
Sep 30, 2021 18.65 Mn